(Q37896795)

25 August 2017

1 reference

title

Immunophenotypic pattern of myeloid populations by flow cytometry analysis (English)

1 reference

25 August 2017

Immunophenotypic Pattern of Myeloid Populations by Flow Cytometry Analysis (English)

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

6 December 2024

1 reference

Wojciech Gorczyca

1

1 reference

25 August 2017

Zhong-Yi Sun

2

1 reference

25 August 2017

William Cronin

3

1 reference

25 August 2017

Xiaoyu Li

4

1 reference

25 August 2017

Sophal Mau

5

1 reference

25 August 2017

Sorina Tugulea

6

1 reference

25 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21722806

6 December 2024

publication date

1 January 2011

1 reference

25 August 2017

2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21722806

6 December 2024

published in

Methods in Cell Biology

1 reference

25 August 2017

volume

103

1 reference

25 August 2017

page(s)

221-266

1 reference

describes a project that uses

25 August 2017

1 reference

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

2

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement

6 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities.

6 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

A practical approach to multicolor flow cytometry for immunophenotyping

6 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes

6 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

6 December 2024

Flow cytometry defended

7

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation

6 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis

6 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study

6 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry is becoming an indispensable tool in leukemia diagnosis and classification

6 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias

6 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometric analysis of lymphomas

6 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Analysis of lymphomas by flow cytometry. Current and emerging strategies

6 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.

6 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

6 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

6 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometric immunophenotyping for hematologic neoplasms

6 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry: new guidelines to support its clinical application

6 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Immunophenotypic analysis of myelodysplastic syndromes

6 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Clinical and biologic features of CD4+CD56+ malignancies

6 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.

6 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

6 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

6 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.

6 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Differential diagnosis of T-cell lymphoproliferative disorders by flow cytometry multicolor immunophenotyping. correlation with morphology

6 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML)

6 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry

6 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry

6 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow Cytometry: Recent Advances in Diagnosis and Monitoring of Leukemia

6 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Differences in CD33 intensity between various myeloid neoplasms

6 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication

6 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique

6 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

6 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

6 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.

6 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Diagnostic flow cytometry for low-grade myelodysplastic syndromes

6 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

6 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions

6 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes

6 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common

6 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen

6 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls

6 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

6 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

6 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry

6 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Minimal residual disease monitoring by flow cytometry

6 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.

6 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Flow cytometry in the diagnosis of acute leukemia

6 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

6 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

6 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

WHO-EORTC classification for cutaneous lymphomas

6 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.

6 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-385493-3.00010-3

6 December 2024

Identifiers

1 reference

25 August 2017

1 reference